Quality screen, uneven payout. Every holding has raised its dividend for at least 25 straight years, and equal weighting keeps each name near 1–2% of the fund. The fund’s own payout does not rise as steadily: it fell in 2022 as the equal-weight index rotated, the yield is a modest 2.01%, and the 0.35% fee takes a larger cut than cheaper dividend ETFs charge.
Key risk: Equal weighting is the risk as well as the screen: annual reconstitution resets every holding to the same weight and swaps names in and out, so the fund’s distribution can fall in a year when its holdings’ own dividends rose — 2022 is the recent example.
Changes if: The payout grows through a full rotation cycle without a down year and the fee moves toward cheaper dividend-ETF levels — or, the other way, holdings start losing Aristocrat status faster than new ones qualify, shrinking the eligible list the fund can hold.
- ✓Coverage check: Every holding is an S&P 500 company with at least 25 consecutive years of dividend increases, equal-weighted across 71 holdings — no single payer carries the distribution.
- !Yield check: 2.01% trailing — $1.17 over the last four quarters at the $58.32 Oct 23 close — is real income from profitable payers, not distress yield, but it is modest and the 0.35% fee comes out of the fund’s income first.
- !Dividend growth check: Calendar payouts rose from $0.87 in 2022 to $1.02 in 2024 and $1.11 in 2025, but the path is uneven: the 2022 total fell about 6% from 2021, with earlier falls in 2019 and 2017, as annual equal-weight rotation changed the mix.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.